Filing Details

Accession Number:
0000914190-15-000035
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-02-13 18:02:44
Reporting Period:
2015-02-11
Filing Date:
2015-02-13
Accepted Time:
2015-02-13 18:02:44
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1180145 Cardiovascular Systems Inc CSII Surgical & Medical Instruments & Apparatus (3841) 411698056
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1304318 David Martin 651 Campus Drive
St. Paul MN 55112
President And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2015-02-11 1,000 $36.55 371,689 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 850 Indirect By child
Common Stock 350 Indirect By child
Common Stock 850 Indirect By child
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Stock Option (right to buy) $8.83 2017-02-14 20,800 20,800 Direct
Common Stock Stock Option (right to buy) $7.90 2017-06-11 90,580 90,580 Direct
Common Stock Stock Option (right to buy) $12.15 2017-12-11 234,395 234,395 Direct
Common Stock Stock Option (right to buy) $8.75 2019-03-01 32,350 32,350 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2017-02-14 20,800 20,800 Direct
2017-06-11 90,580 90,580 Direct
2017-12-11 234,395 234,395 Direct
2019-03-01 32,350 32,350 Direct
Footnotes
  1. Sale of shares to provide funds to satisfy certain tax obligations of the reporting person.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.34 to $36.73 inclusive. The reporting person undertakes to provide Cardiovascular Systems, Inc., any security holder of Cardiovascular Systems, Inc. or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  3. Fully exercisable.